Literature DB >> 24831769

Assessment of the safety and efficiency of using an age-adjusted D-dimer threshold to exclude suspected pulmonary embolism.

Scott C Woller1, Scott M Stevens2, Daniel M Adams3, R Scott Evans4, James F Lloyd4, Gregory L Snow5, Joseph R Bledsoe6, David Z Gay7, Richard M Patten8, Valerie T Aston9, C Gregory Elliott2.   

Abstract

BACKGROUND: D-dimer levels increase with age, and research has suggested that using an age-adjusted D-dimer threshold may improve diagnostic efficiency without compromising safety. The objective of this study was to assess the safety of using an age-adjusted D-dimer threshold in the workup of patients with suspected pulmonary embolism (PE).
METHODS: We report the outcomes of 923 patients aged > 50 years presenting to our ED with suspected PE, a calculated Revised Geneva Score (RGS), and a D-dimer test. All patients underwent CT pulmonary angiography (CTPA). We compared the false-negative rate for PE of a conventional D-dimer threshold with an age-adjusted D-dimer threshold and report the proportion of patients for whom an age-adjusted D-dimer threshold would obviate the need for CTPA.
RESULTS: Among 104 patients with a negative conventional D-dimer test result and an RGS ≤ 10, no PE was observed within 90 days (false-negative rate, 0%; 95% CI, 0%-2.8%). Among 273 patients with a negative age-adjusted D-dimer result and an RGS ≤ 10, four PEs were observed within 90 days (false-negative rate, 1.5%; 95% CI, 0.4%-3.7%). We observed an 18.3% (95% CI, 15.9%-21.0%) absolute reduction in the proportion of patients aged > 50 years who would merit CTPA by using an age-adjusted D-dimer threshold compared with a conventional D-dimer threshold.
CONCLUSIONS: Use of an age-adjusted D-dimer threshold reduces imaging among patients aged > 50 years with an RGS ≤ 10. Although the adoption of an age-adjusted D-dimer threshold is probably safe, the CIs surrounding the additional 1.5% of PEs missed necessitate prospective study before this practice can be adopted into routine clinical care.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24831769     DOI: 10.1378/chest.13-2386

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  MicroRNAs are novel non-invasive diagnostic biomarkers for pulmonary embolism: a meta-analysis.

Authors:  Han-Yu Deng; Gang Li; Jun Luo; Zhi-Qiang Wang; Xiao-Yan Yang; Yi-Dan Lin; Lun-Xu Liu
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Value of D-dimer levels for the diagnosis of pulmonary embolism: An analysis of 32 cases with computed tomography pulmonary angiography.

Authors:  Hui Gao; Hu Liu; Yanjing Li
Journal:  Exp Ther Med       Date:  2018-06-15       Impact factor: 2.447

3.  Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care.

Authors:  W Frank Peacock; Craig I Coleman; Phil Wells; Gregory J Fermann; Li Wang; Onur Baser; Jeff Schein; Concetta Crivera
Journal:  J Health Econ Outcomes Res       Date:  2019-10-02

4.  Clinical usefulness and safety of an age-adjusted D-dimer cutoff levels to exclude pulmonary embolism: a retrospective analysis.

Authors:  Julio Flores; Jaime García de Tena; Javier Galipienzo; Ángel García-Avello; Esteban Pérez-Rodríguez; José Ignacio Tortuero; Concepción Álvarez; Antonio Ruíz; Ignacio Arribas
Journal:  Intern Emerg Med       Date:  2015-09-07       Impact factor: 3.397

5.  Pulmonary Embolism Masquerading as High Altitude Pulmonary Edema at High Altitude.

Authors:  Prativa Pandey; Benu Lohani; Holly Murphy
Journal:  High Alt Med Biol       Date:  2016-10-21       Impact factor: 1.981

6.  Natural Language Processing Performance for the Identification of Venous Thromboembolism in an Integrated Healthcare System.

Authors:  Bela Woller; Austin Daw; Valerie Aston; Jim Lloyd; Greg Snow; Scott M Stevens; Scott C Woller; Peter Jones; Joseph Bledsoe
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

7.  The Predictive Value of microRNA-134 and microRNA-1233 for the Early Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Pulmonary Embolism.

Authors:  Ling Peng; Li Han; Xiao-Ning Li; Ya-Fang Miao; Fei Xue; Chao Zhou
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.